Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes safety, pharmacokinetics, and pharmacodynamics evaluation of DNL952 in adults with late-onset Pompe disease. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Pompe Disease
• Pompe Disease

Drugs mentioned

• DNL952 (DNL952)

Snippet

Sponsor: Denali Therapeutics Inc. | Conditions: Late-onset Pompe Disease | Phase 1 | Status: NOT_YET_RECRUITING